Covered recipient · General Payments record
PRASAD MATHEW
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2018–2024
$80,558.09
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $74,325.00 | 33 |
| Travel and Lodging | $926.28 | 1 |
| Education | $121.46 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $74,325.00 | 33 |
| Octapharma USA, Inc. | $926.28 | 1 |
| CSL Behring | $121.46 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| CSL Behring | $60.73 | 08/29/2024 | Education | Undisputed | 01/23/2026 | 1134599535 | CMS |
| CSL Behring | $60.73 | 08/29/2024 | Education | Undisputed | 01/23/2026 | 1134599537 | CMS |
| CSL Plasma Inc. | $1,225.00 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599549 | CMS |
| CSL Plasma Inc. | $1,750.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599543 | CMS |
| CSL Plasma Inc. | $650.00 | 05/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599545 | CMS |
| CSL Plasma Inc. | $2,100.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599547 | CMS |
| CSL Plasma Inc. | $2,275.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599551 | CMS |
| CSL Plasma Inc. | $3,325.00 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599553 | CMS |
| CSL Plasma Inc. | $1,750.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599555 | CMS |
| CSL Plasma Inc. | $1,400.00 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134599557 | CMS |
| CSL Plasma Inc. | $2,975.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130953 | CMS |
| CSL Plasma Inc. | $1,750.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130955 | CMS |
| CSL Plasma Inc. | $2,100.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130957 | CMS |
| CSL Plasma Inc. | $1,750.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142131001 | CMS |
| CSL Plasma Inc. | $2,100.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130959 | CMS |
| CSL Plasma Inc. | $2,800.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130961 | CMS |
| CSL Plasma Inc. | $2,100.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130963 | CMS |
| CSL Plasma Inc. | $1,750.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130965 | CMS |
| CSL Plasma Inc. | $2,450.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130967 | CMS |
| CSL Plasma Inc. | $2,100.00 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130969 | CMS |
| CSL Plasma Inc. | $2,975.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130971 | CMS |
| CSL Plasma Inc. | $3,325.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130973 | CMS |
| CSL Plasma Inc. | $2,800.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130975 | CMS |
| CSL Plasma Inc. | $2,800.00 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130999 | CMS |
| CSL Plasma Inc. | $1,925.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130977 | CMS |
| CSL Plasma Inc. | $2,450.00 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130979 | CMS |
| CSL Plasma Inc. | $2,275.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130981 | CMS |
| CSL Plasma Inc. | $3,150.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130983 | CMS |
| CSL Plasma Inc. | $2,800.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130985 | CMS |
| CSL Plasma Inc. | $2,100.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130987 | CMS |
| CSL Plasma Inc. | $2,800.00 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130989 | CMS |
| CSL Plasma Inc. | $2,450.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130991 | CMS |
| CSL Plasma Inc. | $1,750.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130993 | CMS |
| CSL Plasma Inc. | $2,100.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130995 | CMS |
| CSL Plasma Inc. | $2,275.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142130997 | CMS |
| Octapharma USA, Inc. | $926.28 | 12/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142316890 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.